Nanoform Finland (Finland) Analysis

NANOFH Stock  EUR 1.21  0.02  1.63%   
Nanoform Finland Plc is overvalued with Real Value of 1.1 and Hype Value of 1.21. The main objective of Nanoform Finland stock analysis is to determine its intrinsic value, which is an estimate of what Nanoform Finland Plc is worth, separate from its market price. There are two main types of Nanoform Finland's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Nanoform Finland's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Nanoform Finland's stock to identify patterns and trends that may indicate its future price movements.
The Nanoform Finland stock is traded in Finland on Helsinki Exchange, with the market opening at 10:00:00 and closing at 18:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Finland. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Nanoform Finland's ongoing operational relationships across important fundamental and technical indicators.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nanoform Finland Plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census.

Nanoform Stock Analysis Notes

About 25.0% of the company outstanding shares are owned by corporate insiders. The book value of Nanoform Finland was now reported as 1.18. The company recorded a loss per share of 0.3. Nanoform Finland Plc had not issued any dividends in recent years. Nanoform Finland Oy provides nanotechnology and drug particle engineering services for the pharmaceutical and biotechnology industries in Finland and internationally. The company was founded in 2015 and is headquartered in Helsinki, Finland. Nanoform Finland operates under Biotechnology classification in Finland and is traded on Helsinki Exchange. It employs 87 people. To find out more about Nanoform Finland Plc contact Pr Haeggstrom at 358 2937 00150 or learn more at https://www.nanoform.com.

Nanoform Finland Plc Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Nanoform Finland's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Nanoform Finland Plc or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Nanoform Finland Plc may become a speculative penny stock
Nanoform Finland Plc had very high historical volatility over the last 90 days
The company reported the revenue of 1.95 M. Net Loss for the year was (19.69 M) with profit before overhead, payroll, taxes, and interest of 1.79 M.
Nanoform Finland Plc has accumulated about 94.82 M in cash with (14.35 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.31, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Roughly 25.0% of the company outstanding shares are owned by corporate insiders

Nanoform Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 203.04 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Nanoform Finland's market, we take the total number of its shares issued and multiply it by Nanoform Finland's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Technical Drivers

As of the 1st of February, Nanoform Finland secures the Standard Deviation of 4.6, risk adjusted performance of (0.04), and Mean Deviation of 3.22. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Nanoform Finland Plc, as well as the relationship between them.

Nanoform Finland Plc Price Movement Analysis

Execute Study
The output start index for this execution was thirty-five with a total number of output elements of twenty-six. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Nanoform Finland middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Nanoform Finland Plc. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Nanoform Finland Outstanding Bonds

Nanoform Finland issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Nanoform Finland Plc uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Nanoform bonds can be classified according to their maturity, which is the date when Nanoform Finland Plc has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Nanoform Finland Predictive Daily Indicators

Nanoform Finland intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Nanoform Finland stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Nanoform Finland Forecast Models

Nanoform Finland's time-series forecasting models are one of many Nanoform Finland's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Nanoform Finland's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Nanoform Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Nanoform Finland prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Nanoform shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Nanoform Finland. By using and applying Nanoform Stock analysis, traders can create a robust methodology for identifying Nanoform entry and exit points for their positions.
Nanoform Finland Oy provides nanotechnology and drug particle engineering services for the pharmaceutical and biotechnology industries in Finland and internationally. The company was founded in 2015 and is headquartered in Helsinki, Finland. Nanoform Finland operates under Biotechnology classification in Finland and is traded on Helsinki Exchange. It employs 87 people.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Nanoform Finland to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Theme Ratings Now

   

Theme Ratings

Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
All  Next Launch Module

Complementary Tools for Nanoform Stock analysis

When running Nanoform Finland's price analysis, check to measure Nanoform Finland's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nanoform Finland is operating at the current time. Most of Nanoform Finland's value examination focuses on studying past and present price action to predict the probability of Nanoform Finland's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nanoform Finland's price. Additionally, you may evaluate how the addition of Nanoform Finland to your portfolios can decrease your overall portfolio volatility.
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities